Redmile Group, LLC - 01 Jul 2024 Form 4 Insider Report for ADC Therapeutics SA (ADCT)

Role
10%+ Owner
Signature
By: /s/ Jeremy Green, Managing Member of Redmile Group, LLC
Issuer symbol
ADCT
Transactions as of
01 Jul 2024
Net transactions value
+$2,248,000
Form type
4
Filing time
03 Jul 2024, 20:00:13 UTC
Previous filing
02 Jul 2024
Next filing
02 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADCT Common Shares, par value CHF 0.08 per share Purchase $1,124,000 +400,000 +2.6% $2.81 15,669,217 01 Jul 2024 See Footnotes F1, F2
transaction ADCT Common Shares, par value CHF 0.08 per share Purchase $1,124,000 +400,000 +3.2% $2.81 12,995,040 01 Jul 2024 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are directly owned by certain private investment vehicles and sub-advised accounts managed by Redmile Group, LLC ("Redmile"), including RedCo II Master Fund, L.P. ("RedCo II" and collectively with the other private investment vehicles and sub-advised accounts managed by Redmile, the "Redmile Clients"). Redmile may be deemed to beneficially own the reported securities as investment manager of the Redmile Clients.
F2 The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the "Reporting Persons") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F3 These securities are directly owned by RedCo II and this transaction is a repetition of the same transaction disclosed above in the first row to disclose this fund's direct ownership.

Remarks:

The purchases reported herein were effected within a period of less than six months from deemed sales reported in the Form 4 filed by the Reporting Persons on February 9, 2024. However, the purchases reported herein were effected at a price higher than certain previous deemed purchases that were also reported in the Form 4 filed February 9, 2024, such that no additional profits have been earned by the Reporting Persons, and so the Reporting Persons have no additional liability under Section 16(b).